comparemela.com

Latest Breaking News On - ஐ.நா. குழந்தைகள் நிதி யூநிஸெஃப் - Page 6 : comparemela.com

Welcome To IANS Live - TopStory - 3 7L babies will be born worldwide on Jan 1, 60K in India: Unicef

Photo Credit: IANS IANSLive New York, Jan 1 (IANS) An estimated 3,71,504 babies will be born around the world on New Year s Day, with about 60,000 babies expected to be born in India alone, UN Children s Fund (Unicef) said on Friday. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 01-January-2021

Welcome To IANS Live - INTERNATIONAL - Over 10 mn children to suffer from acute malnutrition in 2021: Unicef

Unicef appeals funding for 2mn vulnerable Ethiopians

Unicef appeals funding for 2mn vulnerable Ethiopians Follow Newsd On   Addis Ababa, Dec 25 (IANS) The UN Children’s Fund (Unicef) has appealed for a funding worth $116.5 million to help 2.3 million vulnerable Ethiopians. In a statement on Thursday, Unicef said it needs 1the funding to meet the needs of 2.3 million people between December 2020 and January 2021 living in the conflict-ridden northern Tigray state and the adjacent localities in neighbouring Amhara and Afar regions. The UN agency had already developed an emergency response plan for three months from November 2020 to January 2021. The plan was updated on Thursday to readjust to the needs and requirements of vulnerable people living in the three Ethiopian regional states.

Aurobindo Pharma & Covaxx to develop COVID-19 vaccine for India, Unicef

Aurobindo Pharma & Covaxx to develop COVID-19 vaccine for India, Unicef IANS New Delhi; Aurobindo Pharma Limited and Covaxx, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based vaccine to fight Covid-19, for India and the UN Children’s Fund (Unicef) agency. COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate. Commenting on the development, N. Govindarajan, Managing Director, Aurobindo Pharma Limited, said “We are proud to partner with COVAXX in developing the first-ever synthetic peptide-based vaccine to combat the Covid-19 pandemic. This vaccine has immense potential in eliminating shedding, and hence containing, the spread of the pandemic.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.